The DOI matches its Crossref record; 499 of the 499 references it cites were found in a registry or an index.
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 401–499 of 499
Hallucinations and the spectrum of psychosis in Parkinson's disease
Frei, K. P., & Truong, D. D. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.014 · Cited by 45
Population‐based analysis of pathological correlates of dementia in the oldest old
Tanskanen, M., Mäkelä, M., Notkola, I., Myllykangas, L., Rastas, S., Oinas, M., Lindsberg, P. J., Polvikoski, T. M., Tienari, P. J., & Paetau, A. E. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.389 · Cited by 45
Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies
Erskine, D., Thomas, A. J., Attems, J., Taylor, J., McKeith, I. G., Morris, C. M., & Khundakar, A. A. (2017) · Movement Disorders · doi:10.1002/mds.26887 · Cited by 44
Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders
Nouraei, N., Mason, D. M., Miner, K. M., Carcella, M. A., Bhatia, T. N., Dumm, B. K., Soni, D., Johnson, D. A., Luk, K. C., & Leak, R. K. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.017 · Cited by 44
Mapping Cortical Atrophy in Parkinson's Disease Patients with Dementia
Hwang, K., Beyer, M. K., Green, A. E., Chung, C., Thompson, P. M., Janvin, C. C., Larsen, J. O., Aarsland, D., & Apostolova, L. G. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120151 · Cited by 43
Cognitive impairment and dementia in Parkinson's disease
Marder, K. S. (2010) · Movement Disorders · doi:10.1002/mds.22787 · Cited by 43
Fereshtehnejad, S.-M., Religa, D., Westman, Lökk, J., Eriksdotter, M., & Aarsland, D. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s45840 · Cited by 42
Prevalence of cerebrovascular lesions in patients with Lewy body dementia: A neuropathological study
Reuck, J. D., Deramecourt, V., Cordonnier, C., Leys, D., Pasquier, F., & Maurage, C. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.11.005 · Cited by 41
Fukui, T., Owan, Y., Yamazaki, T., & Kinno, R. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000351423 · Cited by 41
Llorens, F., Schmitz, M., Varges, D., Kruse, N., Gotzmann, N., Gmitterová, K., Mollenhauer, B., & Zerr, I. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8259-0 · Cited by 41
Buongiorno, M., Antonelli, F., Compta, Y., Fernandez, Y., Pavía, J., Lomeña, F., Ríos, J., Ramírez, I., García, J. R., Soler, M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160698 · Cited by 41
Berlyand, Y., Weintraub, D. A., Xie, S. X., Mellis, I. A., Doshi, J. J., Rick, J. H., McBride, J. D., Davatzikos, C. A., Shaw, L. M. J., Hurtig, H. I., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147319 · Cited by 40
Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry
Graff‐Radford, J., Lesnick, T. G., Boeve, B. F., Przybelski, S. A., Jones, D. T., Senjem, M. L., Gunter, J. L., Ferman, T. J., Knopman, D. S., Murray, M. E., et al. (2016) · Movement Disorders · doi:10.1002/mds.26666 · Cited by 40
Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias
Bohnen, N. I., Müller, M. L. T. M., & Frey, K. A. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0789-z · Cited by 40
Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease
Johar, I., Mollenhauer, B., & Aarsland, D. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2016.12.001 · Cited by 39
Loss of D opamine T ransporter B inding and C linical S ymptoms in D ementia W ith L ewy B odies
Siepel, F. J., Dalen, I., Grüner, R., Booij, J., Brønnick, K., Buter, T. C. E., & Aarsland, D. (2015) · Movement Disorders · doi:10.1002/mds.26327 · Cited by 38
Walker, Z., McKeith, I. G., Rodda, J. E., Qassem, T., Tatsch, K., Booij, J., Darcourt, J., & O'Brien, J. T. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000380 · Cited by 38
Kaul, T. K., Credle, J. J., Haggerty, T., Oaks, A. W., Masliah, E., & Sidhu, A. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-79 · Cited by 38
H ippocampal α‐synuclein and interneurons in P arkinson's disease: D ata from human and mouse models
Flores‐Cuadrado, A., Úbeda‐Bañón, I., Saiz‐Sánchez, D., de la Rosa‐Prieto, C., & Martínez-Marcos, A. (2016) · Movement Disorders · doi:10.1002/mds.26586 · Cited by 38
Erskine, D., Thomas, A. J., Taylor, J., Savage, M. A., Attems, J., McKeith, I. G., Morris, C. M., & Khundakar, A. A. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.01.005 · Cited by 38
Marquié, M., Locascio, J. J., Rentz, D. M., Becker, J. A., Hedden, T., Johnson, K. A., Growdon, J. H., & Gomperts, S. N. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0052-7 · Cited by 37
White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease
Compta, Y., Buongiorno, M., Bargalló, N., Valldeoriola, F., Muñoz, E., TOLOSA, E. S., Ríos, J., Cámara, A., Fernández, M., & Martí, M. J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.06.009 · Cited by 37
GBA mutations in Parkinson disease: earlier death but similar neuropathological features
Adler, C. H., Beach, T. G., Shill, H. A., Caviness, J. N., Driver‐Dunckley, E. D., Sabbagh, M. N., Patel, A., Sue, L. I., Serrano, G. E., Jacobson, S. A., et al. (2017) · European Journal of Neurology · doi:10.1111/ene.13395 · Cited by 37
Ko, J. H., Katako, A., Aljuaid, M., Goertzen, A. L., Borys, A., Hobson, D. E., Kim, S., & Lee, C. S. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.020 · Cited by 37
Gatt, A. P., Jones, E. L., Francis, P. T., Ballard, C. G., & Bateman, J. E. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.10.045 · Cited by 36
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
Maetzler, W., Deleersnijder, W., Hanssens, V., Bernard, A., Brockmann, K., Marquetand, J., Wurster, I., Rattay, T. W., Roncoroni, L., Schaeffer, E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149349 · Cited by 36
Neuropathology of Parkinson’s Disease
Jellinger, K. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_2 · Cited by 35
Self-citationCerebral Microbleeds in Patients with Dementia with Lewy Bodies and Parkinson Disease Dementia
Kim, S. W., Chung, S. J., Oh, Y., Yoon, J. H., Sunwoo, M. K., Hong, J. Y., Kim, J.-S., & Lee, P. H. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4337 · Cited by 35
Takemoto, M., Sato, K., Hatanaka, N., Yamashita, T., Ohta, Y., Hishikawa, N., & Abe, K. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150952 · Cited by 35
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients
Wennström, M., Hall, S., Nägga, K., Londos, E., Minthon, L., & Hansson, O. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0145-y · Cited by 34
Kasanuki, K., Iseki, E., Fujishiro, H., Yamamoto, R., Higashi, S., Minegishi, M., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.10.010 · Cited by 34
Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies
Bernstein, H., Johnson, M. K., Perry, R. H., LeBeau, F. E. N., Dobrowolny, H., Bogerts, B., & Perry, E. K. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2010.01117.x · Cited by 34
Prevalence of Dementia With Lewy Body Symptoms: A Cross-Sectional Study in 40 Swedish Nursing Homes
Zahirovic, I., Wattmo, C., Torisson, G., Minthon, L., & Londos, E. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.03.017 · Cited by 34
Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease
Bäckström, D. C., Domellöf, M., Granåsen, G., Linder, J., Mayans, S., Elgh, E., Zetterberg, H., Blennow, K., & Forsgren, L. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12812 · Cited by 34
Alpha‐synuclein gene duplication: Marked intrafamilial variability in two novel pedigrees
Elia, A. E., Petrucci, S., Fasano, A. A., Guidi, M., Valbonesi, S., Bernardini, L., Consoli, F., Ferraris, A., Albanese, A., & Valente, E. M. (2013) · Movement Disorders · doi:10.1002/mds.25518 · Cited by 33
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease
Mengel, D., Dams, J., Ziemek, J., Becker, J., Balzer‐Geldsetzer, M., Hilker, R., Baudrexel, S., Kalbe, E., Schmidt, N., Witt, K., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.04.013 · Cited by 33
Fujishiro, H., Iseki, E., Kasanuki, K., Murayama, N., Ota, K., Suzuki, M., & Sato, K. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2836 · Cited by 32
Gungor, I., Sarro, L., Graff-Radford, J., Zuk, S. M., Tosakulwong, N., Przybelski, S. A., Lesnick, T., Boeve, B. F., Ferman, T. J., Smith, G. E., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.07.008 · Cited by 31
Dementia with Lewy Bodies and Parkinson's Disease Dementia
Ince, P. G. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch22 · Cited by 31
Bibl, M., Esselmann, H., Lewczuk, P., Trenkwalder, C., Otto, M., Kornhuber, J., Wiltfang, J., & Mollenhauer, B. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/761571 · Cited by 31
Commentary: DLB and PDD: the same or different? Is there a debate?
McKeith, I. G. (2009) · International Psychogeriatrics · doi:10.1017/s1041610208008624 · Cited by 31
Sierra, M., Gelpí, E., Martí, M. J., & Compta, Y. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12308 · Cited by 31
Genome‐wide association study of neocortical Lewy‐related pathology
Peuralinna, T., Myllykangas, L., Oinas, M., Nalls, M. A., Keage, H. A. D., Isoviita, V., Valori, M., Polvikoski, T. M., Paetau, A. E., Sulkava, R. O., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.231 · Cited by 30
Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms
McDermott, K. L., Fisher, N., Bradford, S., Camicioli, R. M., Mortby, M. E., & Ismail, Z. (2017) · International Psychogeriatrics · doi:10.1017/s1041610217002265 · Cited by 30
Akhtar, R. S., Xie, S. X., Brennan, L., Pontecorvo, M. J., Hurtig, H. I., Trojanowski, J. Q., Weintraub, D. A., & Siderowf, A. D. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12290 · Cited by 29
Datta, A., Chai, Y. L., Tan, J. M., Lee, J. H., Francis, P. T., Chen, C., Sze, S. K., & Lai, M. K. P. (2017) · Molecular Brain · doi:10.1186/s13041-017-0316-9 · Cited by 29
Sobów, T. (2007) · PubMed · Cited by 28
Correlation between clinical symptoms and striatal DAT uptake in patients with DLB
Shimizu, S., Hirose, D., Namioka, N., Kanetaka, H., Hirao, K., Hatanaka, H., Takenoshita, N., Kaneko, Y., Ogawa, Y., Umahara, T., et al. (2017) · Annals of Nuclear Medicine · doi:10.1007/s12149-017-1166-3 · Cited by 28
Does attentional dysfunction and thalamic atrophy predict decline in dementia with Lewy bodies?
Watson, R., Colloby, S. J., Blamire, A. M., Wesnes, K. A., Wood, J., & O'Brien, J. T. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.10.006 · Cited by 28
Drug treatments for the neuropsychiatric complications of Parkinson’s disease
Connolly, B. S., & Fox, S. H. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.142 · Cited by 27
The neuropathologic substrate of Parkinson disease dementia
Jellinger, K. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0613-1 · Cited by 27
Self-citationThe prevalence of dementia with Lewy bodies in a rural area of China
Yue, W., Wang, X., Shi, Z., Wang, Y., Liu, S., Liu, S., Zhang, Y., Zhang, Y., Lü, H., Su, W., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.022 · Cited by 27
Disease-modifying therapeutic directions for Lewy-Body dementias
Zhang, Q., Kim, Y.-C., & Narayanan, N. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00293 · Cited by 26
Kurata, T., Kawarabayashi, T., Murakami, T., Miyazaki, K., Morimoto, N., Ohta, Y., Takehisa, Y., Nagai, M., Ikeda, M., Matsubara, E., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21352 · Cited by 26
Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease
Kitayama, M., Wada‐Isoe, K., Irizawa, Y., & Nakashima, K. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.07.017 · Cited by 26
Dysfunction in attentional processing in patients with Parkinson’s disease and visual hallucinations
Hall, J. M., O’Callaghan, C., Shine, J. M., Muller, A. J., Phillips, J. R., Walton, C. C., Lewis, S. J. G., & Moustafa, A. A. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1528-3 · Cited by 26
Kang, J. (2016) · Journal of Movement Disorders · doi:10.14802/jmd.16017 · Cited by 26
Brønnick, K., Breitve, M. H., Rongve, A., & Aarsland, D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160294 · Cited by 26
Jellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_15 · Cited by 25
Self-citationWatanabe, H., Ariyoshi, T., Ozaki, A., Ihara, M., Ono, M., & Saji, H. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.10.010 · Cited by 25
Long reaction times are associated with delayed brain activity in lewy body dementia
Firbank, M., O'Brien, J. T., & Taylor, J. (2017) · Human Brain Mapping · doi:10.1002/hbm.23866 · Cited by 25
Chiba, Y., Fujishiro, H., Ota, K., Kasanuki, K., Arai, H., Hirayasu, Y., Sato, K., & Iseki, E. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4144 · Cited by 24
TREM2 p.R47H substitution is not associated with dementia with Lewy bodies
Walton, R. L., Soto‐Ortolaza, A. I., Murray, M. E., Lorenzo‐Betancor, O., Ogaki, K., Heckman, M. G., Rayaprolu, S., Rademakers, R., Ertekin‐Taner, N., Uitti, R. J., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000085 · Cited by 24
Neuropathology of dementia with Lewy bodies in advanced age: A comparison with Alzheimer disease
Ubhi, K. K., Peng, K. A., Lessig, S. L., Estrella, J., Adame, A., Galasko, D. R., Salmon, D. P., Hansen, L. A., Kawas, C. H., & Masliah, E. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.016 · Cited by 23
Can the disease course in Parkinson’s disease be slowed?
Korczyn, A. D., & Hassin‐Baer, S. (2015) · BMC Medicine · doi:10.1186/s12916-015-0534-x · Cited by 23
Interaction between α-synuclein and tau in Parkinson's disease
Jellinger, K. A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.10.006 · Cited by 22
Self-citationAlghamdi, A. A., Vallortigara, J., Howlett, D. R., Broadstock, M., Hortobágyi, T., Ballard, C. G., Thomas, A. J., O'Brien, J. T., Aarsland, D., Attems, J., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160946 · Cited by 22
Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease
Kasanuki, K., Heckman, M. G., Diehl, N. N., Murray, M. E., Koga, S., Soto, A. I., Ross, O. A., & Dickson, D. W. (2017) · Movement Disorders · doi:10.1002/mds.27184 · Cited by 22
Parkinson's disease susceptibility variants and severity of Lewy body pathology
Heckman, M. G., Kasanuki, K., Diehl, N. N., Koga, S., Soto, A. I., Murray, M. E., Dickson, D. W., & Ross, O. A. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.09.009 · Cited by 21
Dementia with Lewy bodies: prevalence, clinical spectrum and natural history
Ransmayr, G. N. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_21 · Cited by 19
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies
Nielsen, H. M., Hall, S., Surova, Y., Nägga, K., Nilsson, C. F., Londos, E., Minthon, L., Hansson, O., & Wennström, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132246 · Cited by 19
Pathological substrate of dementia in Parkinson's disease—Its relation to DLB and DLBD
Jellinger, K. A. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.09.001 · Cited by 19
Self-citationIaccarino, L., Marelli, S., Iannaccone, S., Magnani, G., Ferini‐Strambi, L., & Perani, D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151000 · Cited by 19
Clinical and neuroimaging characteristics of Chinese dementia with Lewy bodies
Liu, S., Wang, X., Wang, Y., Shi, Z., Cai, L., Liu, S., Han, T., Zhou, Y., Wang, X., Gao, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171802 · Cited by 19
A practical approach to remote longitudinal follow‐up of Parkinson's disease: The FOUND study
Tanner, C. M., Meng, C., Ravina, B. M., Lang, A. E., Kurlan, R., MAREK, K. L., Oakes, D., Seibyl, J. P., Flagg, E., Gauger, L. L., et al. (2014) · Movement Disorders · doi:10.1002/mds.25814 · Cited by 18
Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases
Cervera‐Carles, L., Pagonabarraga, J., Pascual‐Sedano, B., Pástor, P., Campolongo, A., Fortea, J., Blesa, R., Alcolea, D. A., Morenas‐Rodríguez, E., Sala, I., et al. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32390 · Cited by 18
Homma, T., Mochizuki, Y., Takahashi, K., et al. (2015) · Neuropathology · doi:10.1111/neup.12208 · Cited by 18
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
Walker, Z., Moreno, E., Thomas, A. J., Inglis, F., Tabet, N., Stevens, T., Whitfield, T. J., Aarsland, D., Rainer, M. K., Padovani, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003076 · Cited by 18
Huang, S., Chang, C., Lui, C., Chen, N.-C., Lee, C., Wang, P., & Jiang, C. (2014) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000620 · Cited by 17
Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment
Korczyn, A. D. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.053 · Cited by 17
Alexandris, A. S., Liu, A. K. L., Chang, R. C., Pearce, R. K. B., & Gentleman, S. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0249-4 · Cited by 17
Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study
Gazzina, S., Premi, E., Turrone, R., Acosta‐Cabronero, J., Rizzetti, M. C., Cotelli, M. S., Gasparotti, R., Padovani, A., & Borroni, B. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8173-5 · Cited by 17
Szeto, J. Y. Y., Halliday, G. M., Naismith, S. L., & Lewis, S. J. G. (2017) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988717711451 · Cited by 17
IN DEMENTIA WITH LEWY BODIES, BRAAK STAGE DETERMINES PHENOTYPE, NOT LEWY BODY DISTRIBUTION
Jellinger, K. A. (2008) · Neurology · doi:10.1212/01.wnl.0000304033.82293.9a · Cited by 16
Self-citationMori, E., Ikeda, M., Nakagawa, M., Miyagishi, H., & Kosaka, K. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000447586 · Cited by 16
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies
Kun‐Rodrigues, C., Ross, O. A., Orme, T., Shepherd, C. E., Parkkinen, L., Darwent, L., Hernandez, D. G., Ansorge, O., Clark, L. N., Honig, L. S., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.023 · Cited by 15
PITX3 genotype and risk of dementia in Parkinson's disease: A population-based study
Bäckström, D. C., Domellöf, M. E., Granåsen, G., Linder, J., Mayans, S., Elgh, E., Mo, S. J., & Forsgren, L. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.3259 · Cited by 15
Ye, B. S., Lee, Y., Kwak, K., Park, Y.-H., Ham, J. H., Lee, J. J., Shin, N.-Y., Lee, J., Sohn, Y. H., & Lee, P. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160062 · Cited by 14
Sakamoto, F., Shiraishi, S., Tsuda, N., Hashimoto, M., Tomiguchi, S., Ikeda, M., & Yamashita, Y. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160156 · Cited by 13
Alzheimer's disease pathology in synucleinopathies
Attems, J. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30282-4 · Cited by 13
Choi, M. H., Yoon, J. H., & Yong, S. W. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.09.010 · Cited by 13
Low-Abundant Cerebrospinal Fluid Proteome Alterations in Dementia with Lewy Bodies
Dieks, J.-K., Gawinecka, J., Asif, A. R., Varges, D., Gmitterová, K., Streich, J.-H., Dihazi, H., Heinemann, U., & Zerr, I. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121810 · Cited by 11
Iizuka, T., & Kameyama, M. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.09.007 · Cited by 10
Chiba, Y., Iseki, E., Fujishiro, H., Ota, K., Kasanuki, K., Arai, H., Hirayasu, Y., & Sato, K. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12101 · Cited by 9
Cognitive and Neuroanatomical Correlates in Early Versus Late Onset Parkinson’s Disease Dementia
Kim, Y., Lee, D.-K., Cho, K. H., Lee, J. J., Ham, J. H., Ye, B. S., Lee, S., Lee, J., Sohn, Y. H., & Lee, P. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160597 · Cited by 8
Dementia with Lewy bodies and Parkinson's disease dementia - two synucleinopathies
Mosimann, U. P., & McKeith, I. G. (2003) · Cited by 7
Impaired Cognition and the Risk of Parkinson Disease
Brown, E. G., & Tanner, C. M. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1474 · Cited by 7
Thomas, A. J., Attems, J., Colloby, S. J., O'Brien, J. T., McKeith, I. G., Walker, R. W. H., Lee, L., Burn, D. J., Lett, D. J., & Walker, Z. (2017) · Neurology · doi:10.1212/wnl.0000000000004254 · Cited by 6
New cerebrospinal fluid biomarkers in Alzheimer’s disease
Burchell, J. T., & Panegyres, P. K. (2017) · Future Neurology · doi:10.2217/fnl-2017-0009 · Cited by 3
Cited by
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
Circuit Mechanisms of Parkinson’s Disease
McGregor, M. M., & Nelson, A. B. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.004 · Cited by 624
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
Jellinger, K. A., & Korczyn, A. D. (2018) · BMC Medicine · doi:10.1186/s12916-018-1016-8 · Cited by 385
Self-citationNew evidence on the management of Lewy body dementia
Taylor, J.-P., McKeith, I. G., Burn, D. J., Boeve, B. F., Weintraub, D., Bamford, C., Allan, L. M., Thomas, A. J., & O'Brien, J. T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30153-x · Cited by 347
Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia
Gasca-Salas, C., Fernández-Rodríguez, B., Pineda-Pardo, J. A., Rodríguez-Rojas, R., Obeso, I., Hernández-Fernández, F., del Álamo, M., Mata, D., Guida, P., Ordás-Bandera, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21022-9 · Cited by 319
Metadata
- Authors
- Jellinger, K. A.
- Venue
- Journal of Neural Transmission
- Published
- 2017-12-08
- Volume
- 125
- Issue
- 4
- Pages
- 615-650
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2773780551
- Cited by
- 264
- References
- 499
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.